Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Central and peripheral blood pressures in relation to plasma advanced glycation end products in a Chinese population

Subjects

Abstract

We investigated the association of plasma AGE (advanced glycation end product) concentration with central and peripheral blood pressures and central-to-brachial blood pressure amplification in a Chinese population. The study subjects were from a newly established residential area in the suburb of Shanghai. Using the SphygmoCor system, we recorded radial arterial waveforms and derived aortic waveforms by a generalized transfer function and central systolic and pulse pressure by calibration for brachial blood pressure measured with an oscillometric device. The central-to-brachial pressure amplification was expressed as the central-to-brachial systolic blood pressure difference and pulse pressure difference and ratio. Plasma AGE concentration was measured by the enzyme-linked immunosorbent assay method and logarithmically transformed for statistical analysis. The 1051 participants (age, 55.1±13.1 years) included 663 women. After adjustment for sex, age and other confounding factors, plasma AGE concentration was associated with central but not peripheral blood pressures and with some of the pressure amplification indexes. Indeed, each 10-fold increase in plasma AGE concentration was associated with 2.94 mm Hg (P=0.04) higher central systolic blood pressure and 2.39% lower central-to-brachial pulse pressure ratio (P=0.03). In further subgroup analyses, the association was more prominent in the presence of hypercholesterolemia (+8.11 mm Hg, P=0.008) for central systolic blood pressure and in the presence of overweight and obesity (−4.89%, P=0.009), diabetes and prediabetes (−6.26%, P=0.10) or current smoking (−6.68%, P=0.045) for central-to-brachial pulse pressure ratio. In conclusion, plasma AGE concentration is independently associated with central systolic blood pressure and pulse pressure amplification, especially in the presence of several modifiable cardiovascular risk factors.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Basta G, Schmidt AM, De Caterina R . Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004; 63: 582–592.

    Article  CAS  Google Scholar 

  2. Goh SY, Cooper ME . Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008; 93: 1143–1152.

    Article  CAS  Google Scholar 

  3. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci USA 1997; 94: 13915–13920.

    Article  CAS  Google Scholar 

  4. Luevano-Contreras C, Chapman-Novakofski K . Dietary advanced glycation end products and aging. Nutrients 2010; 2: 1247–1265.

    Article  CAS  Google Scholar 

  5. Bohlender JM, Franke S, Stein G, Wolf G . Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005; 289: F645–F659.

    Article  CAS  Google Scholar 

  6. McRobert EA, Young AN, Bach LA . Advanced glycation end-products induce calpain-mediated degradation of ezrin. FEBS J 2012; 279: 3240–3250.

    Article  CAS  Google Scholar 

  7. Hegab Z, Gibbons S, Neyses L, Mamas MA . Role of advanced glycation end products in cardiovascular disease. World J Cardiol 2012; 4: 90–102.

    Article  Google Scholar 

  8. Zieman SJ, Melenovsky V, Kass DA . Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932–943.

    Article  CAS  Google Scholar 

  9. Francis-Sedlak ME, Uriel S, Larson JC, Greisler HP, Venerus DC, Brey EM . Characterization of type I collagen gels modified by glycation. Biomaterials 2009; 30: 1851–1856.

    Article  CAS  Google Scholar 

  10. Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, DeGroof RC et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464–1470.

    Article  CAS  Google Scholar 

  11. Huang QF, Sheng CS, Liu M, Li FH, Li Y, Wang JG . Arterial stiffness and wave reflections in relation to plasma advanced glycation end products in a Chinese population. Am J Hypertens 2013; 26: 754–761.

    Article  CAS  Google Scholar 

  12. Nichols WW, O'Rourke MF . McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles, 5th edn. Oxford University Press: Oxford, UK, 2005, p 624.

    Google Scholar 

  13. Wang KL, Cheng HM, Chuang SY, Spurgeon HA, Ting CT, Lakatta EG et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality? J Hypertens 2009; 27: 461–467.

    Article  CAS  Google Scholar 

  14. Huang CM, Wang KL, Cheng HM, Chuang SY, Sung SH, Yu WC et al. Central versus ambulatory blood pressure in the prediction of all-cause and cardiovascular mortalities. J Hypertens 2011; 29: 454–459.

    Article  CAS  Google Scholar 

  15. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50: 197–203.

    Article  CAS  Google Scholar 

  16. Dart AM, Gatzka CD, Kingwell BA, Willson K, Cameron JD, Liang YL et al. Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension 2006; 47: 785–790.

    Article  CAS  Google Scholar 

  17. Sheng CS, Hu BC, Fan WX, Zou J, Li Y, Wang JG . Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population. Diabetol Metab Syndr 2011; 3: 6.

    Article  CAS  Google Scholar 

  18. Engelen L, Stehouwer CD, Schalkwijk CG . Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab 2013; 15: 677–689.

    Article  CAS  Google Scholar 

  19. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–2605.

    Article  Google Scholar 

  20. Safar ME, Protogerou AD, Blacher J . Statins, central blood pressure, and blood pressure amplification. Circulation 2009; 119: 9–12.

    Article  Google Scholar 

  21. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281–1357.

    Article  CAS  Google Scholar 

  22. Rabbani N, Thornalley PJ . The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy. Diabetes 2014; 63: 50–52.

    Article  CAS  Google Scholar 

  23. Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A . Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res 2007; 30: 219–228.

    Article  Google Scholar 

  24. Ding FH, Li Y, Zhang RY, Zhang Q, Wang JG . Comparison of the SphygmoCor and Omron devices in the estimation of pressure amplification against the invasive catheter measurement. J Hypertens 2013; 31: 86–93.

    Article  CAS  Google Scholar 

  25. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008; 51: 1476–1482.

    Article  CAS  Google Scholar 

  26. Sharman J, Stowasser M, Fassett R, Marwick T, Franklin S . Central blood pressure measurement may improve risk stratification. J Hum Hypertens 2008; 22: 838–844.

    Article  Google Scholar 

  27. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004; 47: 1324–1330.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge the voluntary participation of all study subjects and the technical assistance of the physicians and nurses of Zhaoxiang Community Health Centre (Qingpu District, Shanghai). We also appreciate the expert assistance of Jie Wang and Wei-Zhong Zhang (The Shanghai Institute of Hypertension, China). The present study was financially supported by grants from the National Natural Science Foundation of China (Grant Nos. 81170245, 81270373, 81470533 and 81400312), the Ministry of Science and Technology (Grant No. 2013CB530700 and a grant for China-European Union collaborations (1012)) and the Ministry of Education (NCET-09-0544), Beijing China, the Shanghai Commissions of Science and Technology (Grant Nos. 11QH1402000 and 14ZR1436200) and Education (Grant No. JDY09088), the Shanghai Bureau of Health (Grant Nos. XBR2011004, 20101051 and 20144Y0213) and Shanghai Jiaotong University School of Medicine (Grant No. 14XJ10071).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J-G Wang.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, QF., Sheng, CS., Kang, YY. et al. Central and peripheral blood pressures in relation to plasma advanced glycation end products in a Chinese population. J Hum Hypertens 30, 430–435 (2016). https://doi.org/10.1038/jhh.2015.60

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2015.60

This article is cited by

Search

Quick links